FDA Revokes Emergency Use Authorizations for Certain Respirators and Decontamination Systems
The CDC has now revoked emergency authorizations as production of N95s has increased domestically.
In the earlier days of the COVID-19 pandemic, an emergency use authorization (EUA) from the Centers for Disease Control (CDC) was necessary for the use of non-National Institute for Occupational Safety and Health (NIOSH) approved respirators as well as decontamination reduction systems to disinfect disposable respirators.
Now, these conditions are no longer an issue, making NIOSH-approved N95 masks more accessible to healthcare workers. The FDA has announced the revocation of EUAs for imported, non-NIOSH-approved respirators, as well as decontamination and bioburden reduction systems. This is also supplemented by an increase in domestically manufactured NIOSH-approved N95s available throughout the country.
The CDC urges health care organizations to transition away from crisis capacity conservation strategies that were implemented earlier during the pandemic.
